Skip to main content
IONIS PHARMACEUTICALS INC logo

IONIS PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · IONS ISIN · US4622221004 LEI · 549300SI4ZGLG0BLUZ92 US Manufacturing
Filings indexed 1,797 across all filing types
Latest filing 2022-07-06 Director's Dealing
Country US United States of America
Listing US IONS

About IONIS PHARMACEUTICALS INC

https://www.ionis.com/

Ionis Pharmaceuticals, Inc. is a biopharmaceutical company that discovers and develops RNA- and DNA-targeted therapeutics. Leveraging its expertise in antisense technology and a deep understanding of genetics, the company creates novel medicines designed to treat a wide range of serious diseases. Its development pipeline and marketed products primarily address neurologic and cardiometabolic disorders, as well as other areas with high unmet patient needs, including rare diseases. The company's approach aims to provide new solutions for complex and often intractable conditions by targeting the root cause of disease at the genetic level.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2022-07-06 English
PRIMARY DOCUMENT
Director's Dealing
2022-07-06 English
PRIMARY DOCUMENT
Director's Dealing
2022-07-06 English
PRIMARY DOCUMENT
Director's Dealing
2022-07-06 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used to announce significant events or other material information. The text indicates that the report announces a press release about clinical trial results (eplontersen meeting endpoints in a Phase 3 study). The document is short (2967 characters) and primarily serves to announce the press release, which is attached as an exhibit. There are no financial statements or detailed financial data included. This fits the profile of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories. It is not an earnings release, annual report, or other detailed financial report. Therefore, the correct classification is Regulatory Filings (RNS).
2022-06-21 English
PRIMARY DOCUMENT
Director's Dealing
2022-06-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.